Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

Bayer identifies novel thyroid hormone-like agents with utility in arteriosclerosis

Feb. 12, 2003

Atheroprotective effects of statins

Feb. 11, 2003

Antiarrhythmic benzopyran derivatives prepared and tested at Nissan Chemical

Feb. 11, 2003

Solvay presents new antiarrhythmic potassium channel blockers

Feb. 7, 2003

New series of 5-HT6/5-HT7 ligands discovered at Sigma-Tau

Feb. 6, 2003

Aventis identifies nonpeptide, orally active Ang-(1-7) agonist

Feb. 4, 2003

New endothelin antagonists in early development at GSK

Feb. 4, 2003

Texas Biotechnology to reacquire full sitaxsentan rights

Feb. 3, 2003

Calpastatin overexpression prevents myocardial injury in rat transplant model

Jan. 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...